✦ LIBER ✦

Binding of recombinant human coagulation factor VIII to lipid nanotubes

✍ Scribed by Christopher D.J. Parmenter; Svetla Stoilova-McPhie

Book ID: 113620756
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 709 KB
Volume: 582
Category: Article
ISSN: 0014-5793
DOI: 10.1016/j.febslet.2008.04.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cryo-electron microscopy of coagulation

Cryo-electron microscopy of coagulation Factor VIII bound to lipid nanotubes

✍ Christopher D.J. Parmenter; Matthew C. Cane; Rui Zhang; Svetla Stoilova-McPhie 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 889 KB

The first recombinant human coagulation

The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics

✍ Elisabeth Casademunt; Kristina Martinelle; Mats Jernberg; Stefan Winge; Maya Tie 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB

Binding of human thrombin to human facto

Binding of human thrombin to human factor VIII:RAg

✍ Lena Hau; Barry G. Firkin; Margaret A. Howard 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 678 KB

Definition of the affinity of binding be

Definition of the affinity of binding between human von willebrand factor and coagulation factor VIII

✍ Peter R. Ganz; Judith S. Atkins; Douglas S. Palmer; Anil K. Dudani; Sophia Hashe 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 625 KB

Factor VIII coagulant moiety binds to pl

Factor VIII coagulant moiety binds to platelets by binding to phospholipids of the platelet membrane

✍ W. Muntean; B. Leschnik; J. Haas 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 712 KB

Activated recombinant human coagulation

Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII

✍ Liebman, Howard A.; Chediak, Juan; Fink, Kenneth I.; Galvez, Angel G.; Shah, Pra 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB 👁 2 views

Eight patients with inhibitors to factor VIII (4 hemophilia A and 4 nonhemophilic) were treated with recombinant activated factor VII (rFVIIa) to control severe abdominal bleeding. The recombinant factor was supplied under an open-label, emergency-use program to patients previously unresponsive to o